February 6, 2019
OPTiM Corporation
Sysmex Corporation

OPTiM and Sysmex Enter Alliancein the Area of “Advanced Medicine x AI and IoT”
Accelerating Development and Deployment of IT Solutions and Platforms toSupport Next-Generation Healthcare and Diagnostics
OPTiM Corporation (HQ: Minato-ku, Tokyo, Japan; President: Shunji Sugaya) and Sysmex
Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) have agreed to form acomprehensive business alliance to develop medical information technology (IT) solutions
utilizing artificial intelligence (AI) and the Internet of Things (IoT), and to roll out services
globally in the area of advanced medicine. By connecting the various medical equipment
located at medical institutions over networks and building a platform involving AI to analyze
the information obtained by such equipment, the companies aim to collaborate on initiatives todevelop and commercialize solutions at an early stage that will support next-generation
healthcare and diagnostics.
Information technologies such as AI and IoT are gaining attention as technologies central tothe innovation that will foster next-generation industrial structure. In the healthcare field, inrecent years genetic testing that obtains massive quantities of genetic information has become
more commonplace, and interest in preventive medicine is growing. Against this backdrop, thedata medical institutions handle is becoming increasingly diverse and extensive in scope.
People close to the field expect that AI and IT can be employed to help medical institutions
use this data to optimize their operations and enhance quality, as well as to develop precise
diagnostic methods and technologies for predicting drug efficacy, both of which are requiredfor personalized medicine.
OPTiM and Sysmex have agreed to enter into a comprehensive business alliance in the areaof advanced medicine to combine the extensive expertise and global sales and service
network that Sysmex possesses in the healthcare field with OPTiM’s AI and IoT services (suchas “OPTiM Cloud IoT OS”) and commercialization expertise. The companies intend to create
an open platform that uses AI to analyze the information obtained by medical equipment
connected over a network, and then leverage this platform to develop new medical IT
solutions at an early stage and roll them out globally.
Based on this business alliance, the companies aim to develop services that will support
medical institutions’ efforts to enhance efficiency and quality, such the remote monitoring ofmedical equipment and the use of AI in responding to inquiries. The companies will also
consider the specific scope of collaboration as they aim to develop new disease prediction
systems that combine genomic information with AI analytics, as well as new diagnostic
methods that incorporate AI analytics into image data from various medical tests. The
companies also aim to develop network services that will support remote healthcare andpreventive medicine. In order to make medical IT solutions a business reality at an early stage,
going forward the companies plan to optimize their collaborative structure, possibly through acapital alliance.

As a first step in medical IT solutions in the area of advanced medicine, the two companies will
move forward with the network connection of surgical support robots being developed byMedicaroid Corporation (HQ: Kobe, Japan; President: Yasuhiko Hashimoto), a joint venture
between Sysmex and Kawasaki Heavy Industries, Ltd. The two companies will also work to
jointly develop and verify the utility of services to support the optimization of the entire
operating room.
OPTiM and Sysmex will work to optimize synergies between their two companies andcontribute to the development of healthcare and the healthy lives of people by taking
advantage of sophisticated AI and IoT technologies to develop and commercialize medical
applications and IT platforms.

About OPTiM Corporation
Under the concept of "We make the Net as simple as breathing," OPTiM aims to change thefact that, although the Internet has already become an essential part of our everyday life, there
is still a certain IT literacy necessary to use it. Since its inception, OPTiM engages indeveloping products that allow everyone to benefit from the opportunities and convenience theInternet brings.
Through creating intellectual property by performing proactive research and development in
new areas, OPTiM continuously creates new markets and innovations. OPTiM strives tocreate universal technology/services/business models that positively influence the life ofpeople all over the world.
Company Profile
Name：
Saga office：Tokyo head office：Established：
Paid-in capital：
Lines of business：URL：

OPTiM Corporation
OPTiM Headquarters Bldg. 1 Honjo-machi, Saga, JapanShiodome Building 21F, 1-2-20 Kaigan, Minato-ku, Tokyo, Japan
June 8, 2000
¥443 million (as of November 1, 2018)
Optimal Business (IoT Platform Service, Remote Management
Service, Support Service, Other Services)
https://en.optim.co.jp/

About Sysmex Corporation
In line with its mission of “shaping the advancement of healthcare,” which is defined in the“Sysmex Way,” the corporate philosophy for the Sysmex Group, Sysmex works to contributeto the development of healthcare and the healthy lives of people. Sysmex conducts integrated
R&D, manufacturing and sales and provides support services for the instruments, reagentsand software for in-vitro testing of blood, urine and other bodily fluids. Sysmex supplies its
products to medical institutions in more than 190 countries and regions throughout the world.
In recent years, Sysmex has been expanding its business in the life science domain, using
proprietary technologies in an effort to create new testing and diagnostic value, realize
healthcare that is optimized for individual patients, and help reduce patients’ burdens andenhance their quality of life.
Company ProfileName：
Location：
Established：
Paid-in capital：
Lines of business：
URL：

Sysmex Corporation
1-5-1 Wakinohama-kaigandori, Chuo-ku, Kobe, Japan
February 20, 1968
¥12,276 million (as of March 31, 2018)
Development, manufacture, sales and export/import of diagnostic
instruments, reagents and related software
https://www.sysmex.co.jp/en